Vaxina )Pfizer/Omitron will be ready in the spring

The vaccine against the Omricon mutation will be ready in the spring, so stated Pfizer's director, in Switzerland Sabine Bruckner. We don't know yet if this vaccine will be necessary, Sabine Bruckner said in an interview for Brick, adding that the company is working in two directions. On one side studying that [...]
We don't know yet if this vaccine will be necessary, Sabine Bruckner said in an interview for Brick, adding that the company is working in two directions.
On the one hand by studying how effective the existing vaccine to the coronary is, and on the other hand, by analyzing whether adjustments are needed and what kind of modifications are required.
After the vaccine against Omrico is ready, green light is expected from competent Swiss authorities.










